Health Care & Life Sciences » Pharmaceuticals | ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc. | Ownership

Companies that own ANI Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BlackRock Fund Advisors
1,324,914
11.21%
88,477
0%
06/30/2018
The Vanguard Group, Inc.
498,170
4.22%
20,070
0%
06/30/2018
Dimensional Fund Advisors LP
479,325
4.05%
11,081
0.01%
06/30/2018
Mangrove Partners
396,923
3.36%
20,609
3.57%
06/30/2018
First Analysis Securities Corp.
349,934
2.96%
-38,236
100%
05/16/2018
Nomura Securities Co., Ltd. (Private Banking)
310,115
2.62%
28,134
0.13%
06/30/2018
LSV Asset Management
300,400
2.54%
-5,400
0.02%
06/30/2018
SSgA Funds Management, Inc.
276,476
2.34%
-6,178
0%
06/30/2018
Renaissance Technologies LLC
173,300
1.47%
-2,400
0.01%
06/30/2018
DWS Investment GmbH
171,146
1.45%
14,058
0.01%
06/30/2018

About ANI Pharmaceuticals

View Profile
Address
210 Main Street West
Baudette Minnesota 56623
United States
Employees -
Website http://www.anipharmaceuticals.com
Updated 07/08/2019
ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.